Molecular epidemiology and nitrofurantoin resistance determinants from nitrofurantoin non-susceptible Escherichia coli isolated from urinary tract infections.
The worldwide emergence of multidrug resistant uropathogens has resulted in revival of old antibiotics, like nitrofurantoin (NIT) for treatment of uncomplicated urinary tract infections. We aimed to identify NIT resistance conferring determinants and to investigate the genetic diversity of NIT resistant (NIT-R)Escherichia coli isolates. A total of 6 NIT-R and 3 NIT susceptible clinical isolates ofE. coli obtained from patients with UTI were studied. Susceptibility of isolates to various classes of antibiotics was evaluated by disk diffusion method. The presence of plasmid encoded efflux pump genes oqxA and oqxB was investigated by PCR. The nucleotide sequences of nfsA, nfsB and ribE genes were determined. The genetic relatedness of NIT-R isolates was evaluated by Multilocus sequence typing. All 6 NIT-R isolates were characterized with high level NIT resistance (MICs ≥512 mg/l) and belonged to 5 distinct STs including ST131 (n = 2), ST73, ST405, ST10 and ST354 (n = 1). Amikacin, carbapenems, minocycline, tigecycline, and fosfomycin were the most active agents against the studied uropathogens. TheoqxA and oqxB genes were not detected in any isolate. All NIT-R isolates harbored inactivating genetic alterations in nfsA and nfsB genes (NfsA H11Y, S33 N, S38Y, W212R substitutions, Δg638 (frame shift), Δa64-g73 (frame shift) and NfsB F84S, P45S, W94Stop, E197Stop substitutions, ΔnfsB locus). The ribE of most isolates was unaffected except for one isolate co-harboring deleterious RibE G85C substitution and NfsA/B alterations. It is concluded that NIT resistance in the studied NIT-RE. coli isolates was mainly mediated by nfsA and nfsB alterations.